Oral administration of L-arginine and captopril in rats prevents chronic renal failure by nitric oxide production
Ishmail Ashab(Tel Aviv Sourasky Medical Center), Adrian Iaina(Tel Aviv Sourasky Medical Center), Doron Schwartz, Miriam Blum, Avi Hassner(Tel Aviv Sourasky Medical Center), Donald S. Silverberg(Tel Aviv Sourasky Medical Center), Yoram Wollman(Tel Aviv Sourasky Medical Center), Tamara Chernihovsky(Tel Aviv Sourasky Medical Center), Gary Peer(Tel Aviv Sourasky Medical Center), Shaltiel Cabili(Tel Aviv Sourasky Medical Center)
Cited by 128
Related Papers
Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial
|The Lancet|2000|1k
The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations
|Journal of the American College of Cardiology|2000|729
The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study
|Journal of the American College of Cardiology|2001|645
Randomised crossover trial of naltrexone in uraemic pruritus
|The Lancet|1996|298